Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave...
Health
Food and Drug Administration chief Marty Makary convinced Rick Pazdur to take the role to help bring...
States are choosing not to cover the new weight-loss drugs, sacrificing a chance to stem cancer, diabetes...
An effort to include autism cases could bankrupt the program. The secretary’s anti-vaccine allies prefer it collapse....
Charities that help people pay for care say demand is way up. That’s before scheduled Medicaid and...
The president said an extension of subsidies that help people buy health insurance “may be necessary” to...
The second round of Inflation Reduction Act negotiation prices will kick into effect in 2027.
Thanksgiving is just a few days away and I know that your kitchen might get pretty chaotic...
GOP lawmakers knew subsidies were expiring and premiums would spike, but no clear, conservative alternative emerged.
The HHS secretary said in an interview he ordered the CDC’s website to acknowledge gaps in studies...
Commissioner Marty Makary is pushing back on the demand, sources told POLITICO, in the latest development to...
Workers at the Centers for Disease Control and Prevention told POLITICO that they’re grappling with lack of...
With the enhanced subsidies set to expire at the end of the year, Democrats say they see...
It’s a perilous combination for 165 million people with employer-sponsored health insurance. Premiums are rising, while yearly...
The health secretary and his FDA chief, Marty Makary, can’t agree on how to proceed with vaccine...
There are only a few short weeks left until Obamacare subsidies expire and enrollees start paying much...
The public charge rule makes it harder for legal Medicaid enrollees to obtain a green card.
The insurance industry chose a hard line; pharma negotiated.
The 20 state Affordable Care Act exchanges are prepared for a straightforward extension, but that appears doubtful....
Some candidates and groups see the health secretary as an ideal “boogeyman” for 2026. Others aren’t so...
